1 domain / 2 areas / 1 specialization
Washington University School of Medicine in St. Louis
Data updated
The Program in Psychedelic Research (PiPer) is a partnership between The Healthy Mind Lab, the Washington University Neuroimaging Lab, and Usona Institute. PiPer leverages 30 years of neuroimaging research and four decades of psychiatry research. The group has started with four research projects around neuroimaging data in humans and animals. The university also serves as a site for Usona's Phase II/III trial with 25mg of psilocybin.
Academic Research
0 papersPublished Papers
0
Trial Involvement
13
Distinct Focus Topics
0
Latest Publication
Unknown
Quick Facts
- Type
- academic
- HQ
- United States
- Website
- Visit
Research Landscape
What the 13 registered trials Washington University School of Medicine in St. Louis sponsors or participates in look like when you line them up. Counts come from Blossom’s trial records as of July 2026.
How fast is Washington University School of Medicine in St. Louis research growing?
SourcedRegistered trials by recorded study-start year. Click a year for the running total.
Don't read as total research effort: only registered trials with a recorded start date are counted (13 of 13 tracked). Recent years under-count because of registration lag; striped bars are still filling in or are planned starts.
What's live right now, and what stopped?
SourcedRegistry status of all 13 Washington University School of Medicine in St. Louis trials Blossom tracks. Orange marks trials recruiting or opening.
Don't read stopped trials as failures: trials end early for funding, recruitment, and strategy reasons too. Status is as last synced from the registry; some 'recruiting' trials may already have finished.
Which conditions does Washington University School of Medicine in St. Louis run trials on?
SourcedTrials per primary indication. Orange marks the largest research focus.
Don't read shares as adding to 100%: a trial with several primary indications counts once per indication. Trial volume signals research attention, not evidence quality.
Which compounds appear in Washington University School of Medicine in St. Louis trials?
SourcedTrials per compound. Orange marks the most-studied compound.
Don't read shares as adding to 100%: a trial testing several compounds counts once per compound, and placebo comparator arms are not shown. Trial volume signals research attention, not evidence quality.